Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2007

01-06-2007 | Letter to the Editor

Author Reply

Authors: Jeffrey S. Harman, PhD, Peter J. Veazie, PhD, Jeffrey M. Lyness

Published in: Journal of General Internal Medicine | Issue 6/2007

Login to get access

Excerpt

To the Editor:—Ms. Kinkead raises some excellent points regarding the treatment of depression in rural areas and the associated access and stigma problems that present barriers to quality health care. More research is needed to clearly measure and understand disparities in treatment between rural and urban areas. We believe that quality care for depression includes evidence-based psychotherapies, but access to such treatment is clearly constrained in most rural areas. However, this does not mean that residents of rural areas in need of depression care should be resigned to alternative treatments. Instead, redress of the access and stigma problems in rural communities must be pursued through carefully targeted policies and interventions. Although some treatment options exist for primary care providers practicing in rural areas, viable interventions for improving quality of depression care in rural areas are still in need of development. For example, more primary care providers should be trained to provide the brief primary-care versions of psychotherapies, which have been shown to be effective, such as Problem solving therapy1 or Interpersonal counseling.2 Because of the high prevalence of depression and its adverse impact on quality of life, costs, morbidity, and functioning, and in light of the evidence that psychosocial therapies may be more efficacious than medications for the relatively milder depressive conditions often found in primary care settings,3 the availability of such psychotherapies is a critical component of quality health care. …
Literature
1.
go back to reference Williams JW Jr, Barrett J, Oxman T, et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA. 2000;284(12):1519–26.PubMedCrossRef Williams JW Jr, Barrett J, Oxman T, et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA. 2000;284(12):1519–26.PubMedCrossRef
2.
go back to reference Schulberg HC, Post EP, Raue PJ, Have TT, Miller M, Bruce ML. Treating late-life depression with interpersonal psychotherapy in the primary care sector. Int J Geriatr Psychiatry, In press. Schulberg HC, Post EP, Raue PJ, Have TT, Miller M, Bruce ML. Treating late-life depression with interpersonal psychotherapy in the primary care sector. Int J Geriatr Psychiatry, In press.
3.
go back to reference Pinquart M, Duberstein PR, Lyness JM. Treatments for later life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatr. 2006;163:1493–501.PubMedCrossRef Pinquart M, Duberstein PR, Lyness JM. Treatments for later life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatr. 2006;163:1493–501.PubMedCrossRef
4.
go back to reference Sirey JA, Bruce ML, Alexopoulos GS, et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatr. 2001;158:479–81.PubMedCrossRef Sirey JA, Bruce ML, Alexopoulos GS, et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatr. 2001;158:479–81.PubMedCrossRef
Metadata
Title
Author Reply
Authors
Jeffrey S. Harman, PhD
Peter J. Veazie, PhD
Jeffrey M. Lyness
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 6/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-006-0090-3

Other articles of this Issue 6/2007

Journal of General Internal Medicine 6/2007 Go to the issue

Original Article

Care Management Dosage

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.